1 |
Purcell DF and Martin MA (1993) Alternative splicing of human immunodeficiency virus type 1 mRNA modulates viral protein expression, replication, and infectivity. J Virol 67, 6365-6378
DOI
|
2 |
Ocwieja KE, Sherrill-Mix S, Mukherjee R et al (2012) Dynamic regulation of HIV-1 mRNA populations analyzed by single-molecule enrichment and long-read sequencing. Nucleic Acids Res 40, 10345-10355
DOI
|
3 |
Tazi J, Bakkour N, Marchand V, Ayadi L, Aboufirassi A and Branlant C (2010) Alternative splicing: regulation of HIV-1 multiplication as a target for therapeutic action. Febs j 277, 867-876
DOI
|
4 |
Klotman ME, Kim S, Buchbinder A, DeRossi A, Baltimore D and Wong-Staal F (1991) Kinetics of expression of multiply spliced RNA in early human immunodeficiency virus type 1 infection of lymphocytes and monocytes. Proc Natl Acad Sci U S A 88, 5011-5015
DOI
|
5 |
Long JC and Caceres JF (2009) The SR protein family of splicing factors: master regulators of gene expression. Biochem J 417, 15-27
DOI
|
6 |
Anko ML (2014) Regulation of gene expression programmes by serine-arginine rich splicing factors. Semin Cell Dev Biol 32, 11-21
DOI
|
7 |
Shepard PJ and Hertel KJ (2009) The SR protein family. Genome Biol 10, 242
|
8 |
Mahiet C and Swanson CM (2016) Control of HIV-1 gene expression by SR proteins. Biochem Soc Trans 44, 1417-1425
DOI
|
9 |
Stoltzfus CM and Madsen JM (2006) Role of viral splicing elements and cellular RNA binding proteins in regulation of HIV-1 alternative RNA splicing. Curr HIV Res 4, 43-55
DOI
|
10 |
Ropers D, Ayadi L, Gattoni R et al (2004) Differential effects of the SR proteins 9G8, SC35, ASF/SF2, and SRp40 on the utilization of the A1 to A5 splicing sites of HIV-1 RNA. J Biol Chem 279, 29963-29973
DOI
|
11 |
Erkelenz S, Hillebrand F, Widera M et al (2015) Balanced splicing at the Tat-specific HIV-1 3'ss A3 is critical for HIV-1 replication. Retrovirology 12, 29
|
12 |
Exline CM, Feng Z and Stoltzfus CM (2008) Negative and positive mRNA splicing elements act competitively to regulate human immunodeficiency virus type 1 vif gene expression. J Virol 82, 3921-3931
DOI
|
13 |
Asang C, Hauber I and Schaal H (2008) Insights into the selective activation of alternatively used splice acceptors by the human immunodeficiency virus type-1 bidirectional splicing enhancer. Nucleic Acids Res 36, 1450-1463
DOI
|
14 |
Caputi M, Freund M, Kammler S, Asang C and Schaal H (2004) A bidirectional SF2/ASF- and SRp40-dependent splicing enhancer regulates human immunodeficiency virus type 1 rev, env, vpu, and nef gene expression. J Virol 78, 6517-6526
DOI
|
15 |
Jacquenet S, Decimo D, Muriaux D and Darlix JL (2005) Dual effect of the SR proteins ASF/SF2, SC35 and 9G8 on HIV-1 RNA splicing and virion production. Retrovirology 2, 33
|
16 |
Somberg M, Li X, Johansson C et al (2011) Serine/arginine-rich protein 30c activates human papillomavirus type 16 L1 mRNA expression via a bimodal mechanism. J Gen Virol 92, 2411-2421
|
17 |
Dhanjal S, Kajitani N, Glahder J, Mossberg AK, Johansson C and Schwartz S (2015) Heterogeneous nuclear ribonucleoprotein C proteins interact with the human papillomavirus type 16 (HPV16) early 3'-untranslated region and alleviate suppression of HPV16 late L1 mRNA splicing. J Biol Chem 290, 13354-13371
DOI
|
18 |
Makwaga O, Mulama DH, Muoma J and Mwau M (2021) Correlation of HIV-1 drug resistant mutations and virologic failure. Pan Afr Med J 39, 180
|
19 |
Dlamini Z and Hull R (2017) Can the HIV-1 splicing machinery be targeted for drug discovery? HIV AIDS (Auckl) 9, 63-75
DOI
|
20 |
Ji X, Zhou Y, Pandit S et al (2013) SR proteins collaborate with 7SK and promoter-associated nascent RNA to release paused polymerase. Cell 153, 855-868
DOI
|
21 |
Paz S, Krainer AR and Caputi M (2014) HIV-1 transcription is regulated by splicing factor SRSF1. Nucleic Acids Res 42, 13812-13823
DOI
|
22 |
Caceres JF, Screaton GR and Krainer AR (1998) A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm. Genes Dev 12, 55-66
DOI
|
23 |
Swanson CM, Sherer NM and Malim MH (2010) SRp40 and SRp55 promote the translation of unspliced human immunodeficiency virus type 1 RNA. J Virol 84, 6748-6759
DOI
|
24 |
Swartz JE, Bor YC, Misawa Y, Rekosh D and Hammarskjold ML (2007) The shuttling SR protein 9G8 plays a role in translation of unspliced mRNA containing a constitutive transport element. J Biol Chem 282, 19844-19853
DOI
|
25 |
Wong RW, Balachandran A, Ostrowski MA and Cochrane A (2013) Digoxin suppresses HIV-1 replication by altering viral RNA processing. PLoS Pathog 9, e1003241
|
26 |
Jablonski JA and Caputi M (2009) Role of cellular RNA processing factors in human immunodeficiency virus type 1 mRNA metabolism, replication, and infectivity. J Virol 83, 981-992
DOI
|
27 |
Weber J (2001) The pathogenesis of HIV-1 infection. Br Med Bull 58, 61-72
|
28 |
Zhou Z and Fu XD (2013) Regulation of splicing by SR proteins and SR protein-specific kinases. Chromosoma 122, 191-207
DOI
|
29 |
Jeong S (2017) SR proteins: binders, regulators, and connectors of RNA. Mol Cells 40, 1-9
DOI
|
30 |
Das S and Krainer AR (2014) Emerging functions of SRSF1, splicing factor and oncoprotein, in RNA metabolism and cancer. Mol Cancer Res 12, 1195-1204
DOI
|
31 |
Sliskovic I, Eich H and Muller-McNicoll M (2022) Exploring the multifunctionality of SR proteins. Biochem Soc Trans 50, 187-198
DOI
|
32 |
Paz S, Lu ML, Takata H, Trautmann L and Caputi M (2015) SRSF1 RNA recognition motifs are strong inhibitors of HIV-1 replication. J Virol 89, 6275-6286
DOI
|
33 |
Tacke R and Manley JL (1995) The human splicing factors ASF/SF2 and SC35 possess distinct, functionally significant RNA binding specificities. EMBO J 14, 3540-3551
DOI
|